Sierra Oncology, Inc. (SRRA:NASDAQ) soared at $0.49, a gain of 28.8%. The stock got featured on our News Catalysts scanner on Sat 21 Dec 19 at 07:45 AM in the 'PUBLIC OFFERING' category. From Thu 19 Dec 19, the stock recorded 35.71% Up Days and 33.33% Green Days
The stock spiked on Mon 09 Dec 19 at $0.55 with a volume of 9M+, and its share price has been moving sideways in recent weeks.
About Sierra Oncology, Inc. (SRRA:NASDAQ)
Sierra Oncology Inc is a clinical-stage drug development company engaged in next generation DNA Damage Response (DDR) therapeutics for the treatment of patients with cancer.
Top 10 Gainers:
- Adaptimmune Therapeutics plc (ADAP:NASDAQ), 200%
- Dare Bioscience, Inc. (DARE:NASDAQ), 97.6%
- NantKwest, Inc. (NK:NASDAQ), 91.01%
- Aethlon Medical, Inc. (AEMD:NASDAQ), 50.4%
- Cleveland BioLabs, Inc. (CBLI:NASDAQ), 46.15%
- Proteon Therapeutics, Inc. (PRTO:NASDAQ), 30.5%
- iFresh Inc. (IFMK:NASDAQ), 29.67%
- Sierra Oncology, Inc. (SRRA:NASDAQ), 28.77%
- Primo Water Corporation (PRMW:NASDAQ), 25.43%
- Cardlytics, Inc. (CDLX:NASDAQ), 24.65%